BfArM
- Status: approved
Abrocitinib 200 MG Oral Tablet (abrocitinib-200-mg-oral-tablet) regulatory status in Germany.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. BfArM has authorised it.
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.